Public health
ECDC urges action as antibiotic resistance spreads
ECDC reported a 72% increase since 2019 in bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae.

The European Centre for Disease Prevention and Control urged public health authorities to act to preserve antibiotic effectiveness, saying resistant bacteria are spreading and treatment options are becoming more limited. ECDC said Europe is not on track to meet several of its 2030 targets to counter antimicrobial resistance.
ECDC said carbapenem-resistant Klebsiella pneumoniae has accounted for a 72% increase in bloodstream infections since 2019. These infections can cause serious illness and are linked to a high mortality rate. ECDC said 90% of human antibiotic consumption occurs in community or outpatient settings, and its 2026 campaign focuses on children. The campaign reminds caregivers that many common childhood illnesses are caused by viruses and do not require antibiotics.
ECDC said reaching the 2030 targets will require sustained action, including infection prevention and control, antimicrobial stewardship, laboratory capacity and stronger surveillance. It advises that antibiotics be used only when prescribed by a healthcare professional and when medically necessary.


